1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. KEROS THERAPEUTICS INC
Keros Therapeutics Inc XNAS: KROS

Keros Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet m...

Read More
15.59 0.04 (0.26%)
78.46% Fall from 52W High
537.6K
XNAS Volume

XNAS 05 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Keros Therapeutics Inc is on 09 Sep 2025 for the purpose of H.C. Wainwright 27th Annual Global Investment Conference See details
Durability score
High Financial Strength
55.6 / 100
Valuation Score
Mid Valuation
38.7 / 100
Momentum Score
Technically Neutral
56.6 / 100
Mid-range Performer These stocks are with strong quality. Their reasonable financials and technical aspects successfully gather investor's interest. View Similar Embed DVM
Analyst Price Target
23
1Yr Price target upside is 48%
8 analysts

15

S

8

W

2

O

1

T

SWOT Analysis

Keros Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..